IFFInternational Flavors & Fragrances

Materials · Chemicals · NYSE

Employees: 21,500
Headquarters: New York, NY
CEO: J. Erik Fyrwald
Next results: around Feb 10, 2027

The numbers IFF said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.

Of 2 range targets with a reported result: 1 came in above the last range given, 1 within it, 0 below it.

Target	What the company said	Reported	Result
EBITDA (company-defined) Fiscal 2026	Given $2.05B to $2.15B release 2026-02-11 Kept $2.05B to $2.15B release 2026-05-05 Lowered $1.53B to $1.60B release 2026-08-04 Raised $1.55B to $1.60B release 2026-11-03	–	No standard number
The company's words 2026 Financial Guidance … Full year 2026 sales are expected to be in the range of $10.5 billion to $10.8 billion and full year 2026 adjusted operating EBITDA to be in the range of $2.05 billion to $2.15 billio n. release 2026-02-11 The Company continues to expect full year 2026 sales to be in the range of $10.5 billion to $10.8 billion and full year 2026 adjusted operating EBITDA to be in the range of $2.05 billion to $2.15 billion. release 2026-05-05 For the full year 2026 adjusted operating EBITDA is expected to be in the range of $1.53 billion to $1.60 billion, excluding approximately $520 million related to discontinued operations. release 2026-08-04 For the full year 2026 adjusted operating EBITDA is now expected to be in the range of $1.55 billion to $1.60 billion (versus $1.53 billion to $1.60 billion previously). release 2026-11-03
Revenue Fiscal 2026	Given $10.50B to $10.80B release 2026-02-11 Kept $10.50B to $10.80B release 2026-05-05 Lowered $7.40B to $7.60B release 2026-08-04 Raised $7.50B to $7.60B release 2026-11-03	–	Not reported yet
The company's words Full year 2026 sales are expected to be in the range of $10.5 billion to $10.8 billion and full year 2026 adjusted operating EBITDA to be in the range of $2.05 billion to $2.15 billio n. release 2026-02-11 The Company continues to expect full year 2026 sales to be in the range of $10.5 billion to $10.8 billion and full year 2026 adjusted operating EBITDA to be in the range of $2.05 billion to $2.15 billion. release 2026-05-05 For continuing operations, the Company expects full year 2026 sales to be in the range of $7.4 billion to $7.6 billion excluding approximately $3.2 billion related to discontinued operations. release 2026-08-04 The Company now expects full year 2026 sales to be in the range of $7.5 billion to $7.6 billion (versus $7.4 billion to $7.6 billion previously). release 2026-11-03
EBITDA (company-defined) Fiscal 2025 (ended 2025-12-31)	Given $2.00B to $2.15B release 2025-02-18 Kept $2.00B to $2.15B release 2025-05-06 Kept $2.00B to $2.15B release 2025-08-05 Kept $2.00B to $2.15B release 2025-11-04	–	No standard number
The company's words 2025 Financial Guidance … Full year 2025 sales are expected to be in the range of $10.6 billion to $10.9 billion and full year 2025 adjusted operating EBITDA to be in the range of $2 billion to $2.15 billion. release 2025-02-18 The Company continues to expect full year 2025 sales to be in the range of $10.6 billion to $10.9 billion and full year 2025 adjusted operating EBITDA to be in the range of $2 billion to $2.15 billion. release 2025-05-06 The Company continues to expect full year 2025 sales to be in the range of $10.6 billion to $10.9 billion and full year 2025 adjusted operating EBITDA to be in the range of $2 billion to $2.15 billion. release 2025-08-05 The Company continues to expect full year 2025 sales to be in the range of $10.6 billion to $10.9 billion and full year 2025 adjusted operating EBITDA to be in the range of $2 billion to $2.15 billion. release 2025-11-04
Revenue Fiscal 2025 (ended 2025-12-31)	Given $10.60B to $10.90B release 2025-02-18 Kept $10.60B to $10.90B release 2025-05-06 Kept $10.60B to $10.90B release 2025-08-05 Kept $10.60B to $10.90B release 2025-11-04	$10.89B 10-K filed 2026-02-27	Within the range
The company's words Full year 2025 sales are expected to be in the range of $10.6 billion to $10.9 billion and full year 2025 adjusted operating EBITDA to be in the range of $2 billion to $2.15 billion. release 2025-02-18 The Company continues to expect full year 2025 sales to be in the range of $10.6 billion to $10.9 billion and full year 2025 adjusted operating EBITDA to be in the range of $2 billion to $2.15 billion. release 2025-05-06 The Company continues to expect full year 2025 sales to be in the range of $10.6 billion to $10.9 billion and full year 2025 adjusted operating EBITDA to be in the range of $2 billion to $2.15 billion. release 2025-08-05 The Company continues to expect full year 2025 sales to be in the range of $10.6 billion to $10.9 billion and full year 2025 adjusted operating EBITDA to be in the range of $2 billion to $2.15 billion. release 2025-11-04
EBITDA (company-defined) Fiscal 2024 (ended 2024-12-31)	Given $1.90B to $2.10B release 2024-02-20 Raised $2.10B to $2.17B release 2024-08-06	–	No standard number
The company's words 2024 Financial Guidance … Full year 2024 sales are expected to be in the range of $10.8 billion to $11.1 billion and full year 2024 adjusted operating EBITDA to be in the range of $1.9 billion to $2.1 billion. release 2024-02-20 The Company is increasing its expectations for the full year 2024 and now expects full year 2024 sales to be in the range of $11.1 billion to $11.3 billion versus $10.8 billion to $11.1 billion and adjusted operating EBITDA to be in the range of $2.1 billion to $2.17 billion versus $1.9 billion to $2.1 billion. release 2024-08-06
Revenue Fiscal 2024 (ended 2024-12-31)	Given $10.80B to $11.10B release 2024-02-20 Raised $11.10B to $11.30B release 2024-08-06	$11.48B 10-K filed 2025-02-28	Above the range
The company's words Full year 2024 sales are expected to be in the range of $10.8 billion to $11.1 billion and full year 2024 adjusted operating EBITDA to be in the range of $1.9 billion to $2.1 billion. release 2024-02-20 The Company is increasing its expectations for the full year 2024 and now expects full year 2024 sales to be in the range of $11.1 billion to $11.3 billion versus $10.8 billion to $11.1 billion and adjusted operating EBITDA to be in the range of $2.1 billion to $2.17 billion versus $1.9 billion to $2.1 billion. release 2024-08-06

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2023-11-06), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Work on IFF in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/IFF/export.csv") into a cell.